Bausch Health Companies Inc (NYSE:BHC)

25.00
Delayed Data
As of Jun 26
 +0.62 / +2.54%
Today’s Change
17.20
Today|||52-Week Range
28.45
+35.35%
Year-to-Date
John Hempton's Strategy for Finding Shorts and Longs
Jun 25 / GuruFocus NewsGURU - Paid Partner Content
Allergan Up As Analyst Statement Sparks Business Split Rumors
Jun 20 / Zacks.comZAK - Paid Partner Content
Is Bausch Health (BHC) a Great Value Stock Right Now?
Jun 24 / Zacks.comZAK - Paid Partner Content
Bausch + Lomb ULTRA?? Multifocal for Astigmatism Contact Lenses Now Available In the U...
Jun 19 / PR NewswirePRN - Paid Partner Content
Bausch Health (BHC) Catches Eye: Stock Jumps 6.2%
Jun 21 / Zacks.comZAK - Paid Partner Content
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
May 29 / PR NewswirePRN - Paid Partner Content

Today’s Trading

Previous close24.38
Today’s open24.97
Day’s range24.40 - 25.16
Volume6,175,222
Average volume (3 months)4,161,110
Market cap$8.3B
Data as of 4:00pm ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)-272.12%
Earnings growth (this year)+4.30%
Earnings growth (next 5 years)+5.91%
Revenue growth (last year)-3.94%
P/E ratioNM
Price/Sales0.78
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...-0.87-1.35%
SAGESAGE Therapeutics In...-6.95-3.90%
SRPTSarepta Therapeutics...+4.18+3.37%
CTLTCatalent Inc-0.19-0.36%
Data as of 4:02pm ET, 06/26/2019

Financials

Last reporting date--
EPS forecast (this quarter)$1.04
Annual revenue (last year)$8.4B
Annual profit (last year)-$4.1B
Net profit margin-49.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts